Securities: Select Recent Case Experience
Cornerstone Research has worked on recent securities litigation matters spanning across many industries and involving a variety of types of securities and allegations.
5 Questions with Ben Handel: The Use of Algorithms in Healthcare
Professor Ben Handel of the University of California, Berkeley discusses the use, impact, and potential of algorithmic tools in healthcare.
Accounting for the Employee-Employer Relationship in Antitrust Analysis
The authors discuss how failing to account for the incentives and benefits that arise within long-term employee-employer relationships can lead to incomplete and incorrect economic analysis.
Canadian Pacific Railway/Kansas City Southern
The Surface Transportation Board approved the $31 billion acquisition of Kansas City Southern by Canadian Pacific Railway.
Merger Enforcement Considerations: Implications for Venture Capital Markets and Innovation
The authors discuss how M&A is a critically important exit option for venture capitalists and the innovative firms that they fund.
Vellali et al. v. Yale University et al.
A federal jury found for the university defendant in this ERISA matter.
Yesim Richardson Recognized among 50 Women to Watch by Corporate Counsel Business Journal
Cornerstone Research president honored for leadership and mentoring in select group of outstanding business leaders.
Cornerstone Research Recognized by Chambers Global 2023 Guide
The firm continues to earn top rankings on annual list for litigation support.
Recent CAT judgments yield lessons on the collection and submission of economic evidence
The authors provide an economist’s perspective on recent decisions from the Competition Appeal Tribunal.
GCR Live: Law Leaders Europe 2023
Vikram Kumar will discuss issues related to divergence and fragmentation in global antitrust at this annual conference in Brussels.
The Inflation Reduction Act Could Have Unintended Consequences
This article analyzes the potential unintended economic impacts of the Inflation Reduction Act on the pharmaceutical industry.
United States et al. v. UnitedHealth Group Incorporated et al.
Professors Gowrisankaran and Handel testified at trial regarding this proposed $13.8 billion healthcare industry merger.